Green Thumb Industries (GTBIF) Depreciation & Amortization (CF) (2019 - 2026)

Green Thumb Industries (GTBIF) posted Depreciation & Amortization (CF) of $32.4 million for Q1 2026, down 42.41% on a QoQ basis from $56.3 million in Q4 2025, and up 10.21% year-over-year from $29.4 million in Q1 2025.

Green Thumb Industries (GTBIF) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Green Thumb Industries' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $32.4 million for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 10.21% year-over-year to $32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.5 million (up 29.26% YoY) and the FY2025 annual result came in at $145.4 million, up 28.48% from the prior year.
  • Depreciation & Amortization (CF) was $32.4 million for Q1 2026 at Green Thumb Industries, down from $56.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $56.3 million in Q4 2025 and bottomed at $23.0 million in Q1 2022.
  • A 5-year average of $28.7 million and a median of $27.8 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) climbed 0.15% — and 2025, when it surged 94.37%.
  • Green Thumb Industries' Depreciation & Amortization (CF) stood at $25.0 million in 2022, then grew by 9.89% to $27.4 million in 2023, then climbed by 5.58% to $29.0 million in 2024, then jumped by 94.37% to $56.3 million in 2025, then plunged by 42.41% to $32.4 million in 2026.
  • Business Quant data shows GTBIF's Depreciation & Amortization (CF) at $32.4 million in Q1 2026, $56.3 million in Q4 2025, and $30.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Green Thumb Industries 1.63 Bn 1.29 Bn 143.65 Mn 32.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.41 Mn
Mar 31, 2026 32.41 Mn
Dec 31, 2025 56.29 Mn
Dec 31, 2025 56.29 Mn
Sep 30, 2025 30.08 Mn
Sep 30, 2025 30.08 Mn
Jun 30, 2025 29.67 Mn
Jun 30, 2025 29.67 Mn
Mar 31, 2025 29.41 Mn
Mar 31, 2025 29.41 Mn
Dec 31, 2024 28.96 Mn
Dec 31, 2024 28.96 Mn
Sep 30, 2024 28.49 Mn
Sep 30, 2024 28.49 Mn
Jun 30, 2024 27.99 Mn
Jun 30, 2024 27.99 Mn
Mar 31, 2024 27.78 Mn
Mar 31, 2024 27.78 Mn
Dec 31, 2023 27.43 Mn
Dec 31, 2023 27.43 Mn